{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:07:30Z","timestamp":1785517650015,"version":"3.56.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40266-026-01315-8","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:53:55Z","timestamp":1784282035000},"page":"707-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bipolar Disorder in Older Adults: A Comprehensive Overview of Pharmacotherapy Patterns and Clinical Considerations"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0852-0347","authenticated-orcid":false,"given":"Bashar","family":"Asir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-0549","authenticated-orcid":false,"given":"Majd","family":"Al-Soleiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-8192","authenticated-orcid":false,"given":"Balwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"10506","key":"1315_CR1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0140-6736(25)01140-7","volume":"406","author":"B Singh","year":"2025","unstructured":"Singh B, Swartz HA, Cuellar-Barboza AB, Schaffer A, Kato T, Dols A, et al. Bipolar disorder. Lancet. 2025;406(10506):963\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(25)01140-7.","journal-title":"Lancet"},{"issue":"14","key":"1315_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/jama.2023.18588","volume":"330","author":"AA Nierenberg","year":"2023","unstructured":"Nierenberg AA, Agustini B, Kohler-Forsberg O, Cusin C, Katz D, Sylvia LG, et al. Diagnosis and treatment of bipolar disorder: a review. JAMA. 2023;330(14):1370\u201380. https:\/\/doi.org\/10.1001\/jama.2023.18588.","journal-title":"JAMA"},{"key":"1315_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5-TR","author":"MB First","year":"2022","unstructured":"American Psychiatric A, American Psychiatric A, First MB, American Psychiatric A. Diagnostic and statistical manual of mental disorders: DSM-5-TR. Fifth edition, text revision. Washington, DC: American Psychiatric Association Publishing; 2022. https:\/\/doi.org\/10.1176\/appi.books.9780890425787.","edition":"Fifth edition,"},{"issue":"5","key":"1315_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bdi.12419","volume":"18","author":"C Joslyn","year":"2016","unstructured":"Joslyn C, Hawes DJ, Hunt C, Mitchell PB. Is age of onset associated with severity, prognosis, and clinical features in bipolar disorder? A meta-analytic review. Bipolar Disord. 2016;18(5):389\u2013403. https:\/\/doi.org\/10.1111\/bdi.12419.","journal-title":"Bipolar Disord"},{"issue":"2","key":"1315_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11920-020-01216-6","volume":"23","author":"A Shobassy","year":"2021","unstructured":"Shobassy A. Elderly bipolar disorder. Curr Psychiatry Rep. 2021;23(2):5. https:\/\/doi.org\/10.1007\/s11920-020-01216-6.","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"1315_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/YCO.0000000000000883","volume":"36","author":"AJM Beunders","year":"2023","unstructured":"Beunders AJM, Orhan M, Dols A. Older age bipolar disorder. Curr Opin Psychiatry. 2023;36(5):397\u2013404. https:\/\/doi.org\/10.1097\/YCO.0000000000000883.","journal-title":"Curr Opin Psychiatry"},{"issue":"7","key":"1315_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/bdi.12331","volume":"17","author":"M Sajatovic","year":"2015","unstructured":"Sajatovic M, Strejilevich SA, Gildengers AG, Dols A, Al Jurdi RK, Forester BP, et al. A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disord. 2015;17(7):689\u2013704. https:\/\/doi.org\/10.1111\/bdi.12331.","journal-title":"Bipolar Disord"},{"issue":"2","key":"1315_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/bdi.13119","volume":"24","author":"M Sajatovic","year":"2022","unstructured":"Sajatovic M, Dols A, Rej S, Almeida OP, Beunders AJM, Blumberg HP, et al. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Bipolar Disord. 2022;24(2):195\u2013206. https:\/\/doi.org\/10.1111\/bdi.13119.","journal-title":"Bipolar Disord"},{"key":"1315_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.euroneuro.2024.12.001","volume":"92","author":"L Montejo","year":"2025","unstructured":"Montejo L, Sole B, Fico G, Kalman JL, Budde M, Heilbronner U, et al. Contrasting genetic burden for bipolar disorder: early onset versus late onset in an older adult bipolar disorder sample. Eur Neuropsychopharmacol. 2025;92:29\u201337. https:\/\/doi.org\/10.1016\/j.euroneuro.2024.12.001.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1315_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5833","author":"P Lavin","year":"2022","unstructured":"Lavin P, Buck G, Almeida OP, Su CL, Eyler LT, Dols A, et al. Clinical correlates of late-onset versus early-onset bipolar disorder in a global sample of older adults. Int J Geriatr Psychiatry. 2022. https:\/\/doi.org\/10.1002\/gps.5833.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"1315_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.maturitas.2010.02.013","volume":"66","author":"A Vasudev","year":"2010","unstructured":"Vasudev A, Thomas A. \u201cBipolar disorder\u201d in the elderly: what\u2019s in a name? Maturitas. 2010;66(3):231\u20135. https:\/\/doi.org\/10.1016\/j.maturitas.2010.02.013.","journal-title":"Maturitas"},{"issue":"2","key":"1315_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.maturitas.2011.07.005","volume":"70","author":"A Besga","year":"2011","unstructured":"Besga A, Martinez-Cengotitabengoa M, Gonzalez-Ortega I, Gutierrez M, Barbeito S, Gonzalez-Pinto A. The role of white matter damage in late onset bipolar disorder. Maturitas. 2011;70(2):160\u20133. https:\/\/doi.org\/10.1016\/j.maturitas.2011.07.005.","journal-title":"Maturitas"},{"issue":"4","key":"1315_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/bdi.13016","volume":"23","author":"S Bolton","year":"2021","unstructured":"Bolton S, Warner J, Harriss E, Geddes J, Saunders KEA. Bipolar disorder: trimodal age-at-onset distribution. Bipolar Disord. 2021;23(4):341\u201356. https:\/\/doi.org\/10.1111\/bdi.13016.","journal-title":"Bipolar Disord"},{"key":"1315_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.inpsyc.2025.100157","author":"C Wei","year":"1990","unstructured":"Wei C, Shang B, Aihemaiti A, Li H, Zheng Y, Wang C, et al. Global epidemiological survey, burden of disease assessment and spatio-temporal prediction of bipolar disorder from 1990 to 2021 based on spatial clustering analysis. Int Psychogeriatr. 1990. https:\/\/doi.org\/10.1016\/j.inpsyc.2025.100157.","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"1315_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11920-017-0804-8","volume":"19","author":"P Chen","year":"2017","unstructured":"Chen P, Dols A, Rej S, Sajatovic M. Update on the epidemiology, diagnosis, and treatment of mania in older-age bipolar disorder. Curr Psychiatry Rep. 2017;19(8):46. https:\/\/doi.org\/10.1007\/s11920-017-0804-8.","journal-title":"Curr Psychiatry Rep"},{"key":"1315_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2147\/NDT.S100843","volume":"12","author":"IV Rise","year":"2016","unstructured":"Rise IV, Haro JM, Gjervan B. Clinical features, comorbidity, and cognitive impairment in elderly bipolar patients. Neuropsychiatr Dis Treat. 2016;12:1203\u201313. https:\/\/doi.org\/10.2147\/NDT.S100843.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"1315_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/acps.12272","volume":"130","author":"AM Nivoli","year":"2014","unstructured":"Nivoli AM, Murru A, Pacchiarotti I, Valenti M, Rosa AR, Hidalgo D, et al. Bipolar disorder in the elderly: a cohort study comparing older and younger patients. Acta Psychiatr Scand. 2014;130(5):364\u201373. https:\/\/doi.org\/10.1111\/acps.12272.","journal-title":"Acta Psychiatr Scand"},{"key":"1315_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12586","author":"A Dols","year":"2017","unstructured":"Dols A, Korten N, Comijs H, Schouws S, van Dijk M, Klumpers U, et al. The clinical course of late-life bipolar disorder, looking back and forward. Bipolar Disord. 2017. https:\/\/doi.org\/10.1111\/bdi.12586.","journal-title":"Bipolar Disord"},{"issue":"2","key":"1315_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/gps.4465","volume":"32","author":"A Garcia-Lopez","year":"2017","unstructured":"Garcia-Lopez A, Ezquiaga E, De Dios C, Agud JL. Depressive symptoms in early- and late-onset older bipolar patients compared with younger ones. Int J Geriatr Psychiatry. 2017;32(2):201\u20137. https:\/\/doi.org\/10.1002\/gps.4465.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"10265","key":"1315_CR20","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","volume":"396","author":"RS McIntyre","year":"2020","unstructured":"McIntyre RS, Berk M, Brietzke E, Goldstein BI, Lopez-Jaramillo C, Kessing LV, et al. Bipolar disorders. Lancet. 2020;396(10265):1841\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(20)31544-0.","journal-title":"Lancet"},{"key":"1315_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2025.11.006","author":"B Singh","year":"2025","unstructured":"Singh B. Editorial: recognizing atypical depression in youth: advancing precision diagnosis. J Am Acad Child Adolesc Psychiatry. 2025. https:\/\/doi.org\/10.1016\/j.jaac.2025.11.006.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"1315_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s0193-953x(05)70100-3","volume":"22","author":"KI Shulman","year":"1999","unstructured":"Shulman KI, Herrmann N. The nature and management of mania in old age. Psychiatr Clin North Am. 1999;22(3):649\u201365. https:\/\/doi.org\/10.1016\/s0193-953x(05)70100-3.","journal-title":"Psychiatr Clin North Am"},{"key":"1315_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euroneuro.2024.01.004","volume":"82","author":"A Dols","year":"2024","unstructured":"Dols A, Sajatovic M. What is really different about older age bipolar disorder? Eur Neuropsychopharmacol. 2024;82:3\u20135. https:\/\/doi.org\/10.1016\/j.euroneuro.2024.01.004.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1315_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/gps.6073","volume":"39","author":"P Chen","year":"2024","unstructured":"Chen P, Sajatovic M, Briggs FBS, Mulsant B, Dols AA, Gildengers A, et al. Sociodemographic and clinical characteristics of people with oldest older age bipolar disorder in a global sample: results from the global aging and geriatric experiments in bipolar disorder project. Int J Geriatr Psychiatry. 2024;39(2):e6073. https:\/\/doi.org\/10.1002\/gps.6073.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"1315_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/gps.5094","volume":"34","author":"S Strejilevich","year":"2019","unstructured":"Strejilevich S, Szmulewicz A, Igoa A, Marengo E, Caravotta P, Martino D. Episodic density, subsyndromic symptoms, and mood instability in late-life bipolar disorders: a 5-year follow-up study. Int J Geriatr Psychiatry. 2019;34(7):950\u20136. https:\/\/doi.org\/10.1002\/gps.5094.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1315_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fpsyt.2020.00510","volume":"11","author":"H Grunze","year":"2020","unstructured":"Grunze H, Born C. The impact of subsyndromal bipolar symptoms on patient\u2019s functionality and quality of life. Front Psychiatry. 2020;11:510. https:\/\/doi.org\/10.3389\/fpsyt.2020.00510.","journal-title":"Front Psychiatry."},{"issue":"1","key":"1315_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0891988712436683","volume":"25","author":"SV Lala","year":"2012","unstructured":"Lala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol. 2012;25(1):20\u20135. https:\/\/doi.org\/10.1177\/0891988712436683.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1315_CR28","unstructured":"American Psychologic Association. APA guidelines for psychological practice with older adults 2024 [updated May-Jun]. https:\/\/www.apa.org\/practice\/guidelines\/guidelines-psychological-practice-older-adults.pdf. Accessed 19 June 2026."},{"issue":"3","key":"1315_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jad.2008.11.012","volume":"116","author":"F Oostervink","year":"2009","unstructured":"Oostervink F, Boomsma MM, Nolen WA, Board EA. Bipolar disorder in the elderly; different effects of age and of age of onset. J Affect Disord. 2009;116(3):176\u201383. https:\/\/doi.org\/10.1016\/j.jad.2008.11.012.","journal-title":"J Affect Disord"},{"key":"1315_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jad.2019.07.052","volume":"257","author":"M Belvederi Murri","year":"2019","unstructured":"Belvederi Murri M, Respino M, Proietti L, Bugliani M, Pereira B, D\u2019Amico E, et al. Cognitive impairment in late life bipolar disorder: risk factors and clinical outcomes. J Affect Disord. 2019;257:166\u201372. https:\/\/doi.org\/10.1016\/j.jad.2019.07.052.","journal-title":"J Affect Disord"},{"issue":"2","key":"1315_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1192\/bjp.bp.115.180059","volume":"209","author":"OP Almeida","year":"2016","unstructured":"Almeida OP, McCaul K, Hankey GJ, Yeap BB, Golledge J, Flicker L. Risk of dementia and death in community-dwelling older men with bipolar disorder. Br J Psychiatry. 2016;209(2):121\u20136. https:\/\/doi.org\/10.1192\/bjp.bp.115.180059.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1315_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jagp.2019.10.016","volume":"28","author":"SH Lin","year":"2020","unstructured":"Lin SH, Cheng CM, Tsai SJ, Tsai CF, Bai YM, Su TP, et al. A population-based, nationwide longitudinal study of bipolar disorder with incident dementia in Taiwan. Am J Geriatr Psychiatry. 2020;28(5):530\u201341. https:\/\/doi.org\/10.1016\/j.jagp.2019.10.016.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"1315_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/acps.13153","volume":"141","author":"J Velosa","year":"2020","unstructured":"Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo Cardoso T. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr Scand. 2020;141(6):510\u201321. https:\/\/doi.org\/10.1111\/acps.13153.","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"1315_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/NMD.0000000000000720","volume":"205","author":"G Cipriani","year":"2017","unstructured":"Cipriani G, Danti S, Carlesi C, Cammisuli DM, Di Fiorino M. Bipolar disorder and cognitive dysfunction: a complex link. J Nerv Ment Dis. 2017;205(10):743\u201356. https:\/\/doi.org\/10.1097\/NMD.0000000000000720.","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"1315_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bdi.12821","volume":"22","author":"TE Van Rheenen","year":"2020","unstructured":"Van Rheenen TE, Lewandowski KE, Bauer IE, Kapczinski F, Miskowiak K, Burdick KE, et al. Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: an overview of evidence. Bipolar Disord. 2020;22(1):13\u201327. https:\/\/doi.org\/10.1111\/bdi.12821.","journal-title":"Bipolar Disord"},{"key":"1315_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jad.2022.11.066","volume":"323","author":"N Zovetti","year":"2023","unstructured":"Zovetti N, Rossetti MG, Perlini C, Brambilla P, Bellani M. Brain ageing and neurodegeneration in bipolar disorder. J Affect Disord. 2023;323:171\u20135. https:\/\/doi.org\/10.1016\/j.jad.2022.11.066.","journal-title":"J Affect Disord"},{"key":"1315_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/07067437251372190","author":"KC Bodenstein","year":"2025","unstructured":"Bodenstein KC, Lesage M, Lavin P, Schouws S, Orhan M, Beunders A, et al. Anticonvulsant use in older age bipolar disorder in a global sample from the Global Aging and Geriatric Experiments in Bipolar Disorder Project: Utilisation d\u2019anticonvulsivants pour le traitement des troubles bipolaires du sujet \u00e2g\u00e9 aupr\u00e8s d\u2019un \u00e9chantillon mondial provenant du projet GAGE-BD. Can J Psychiatry. 2025. https:\/\/doi.org\/10.1177\/07067437251372190.","journal-title":"Can J Psychiatry"},{"issue":"10","key":"1315_CR38","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40266-018-0579-6","volume":"35","author":"A Vasudev","year":"2018","unstructured":"Vasudev A, Chaudhari S, Sethi R, Fu R, Sandieson RM, Forester BP. A review of the pharmacological and clinical profile of newer atypical antipsychotics as treatments for bipolar disorder: considerations for use in older patients. Drugs Aging. 2018;35(10):887\u201395. https:\/\/doi.org\/10.1007\/s40266-018-0579-6.","journal-title":"Drugs Aging"},{"issue":"2","key":"1315_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97\u2013170. https:\/\/doi.org\/10.1111\/bdi.12609.","journal-title":"Bipolar Disord"},{"key":"1315_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1176\/appi.focus.20230009","volume":"21","author":"K Keramatian","year":"2023","unstructured":"Keramatian K, Chithra NK, Yatham LN. The CANMAT and ISBD guidelines for the treatment of bipolar disorder: summary and a 2023 update of evidence. Focus (Madison). 2023;21:344\u201353. https:\/\/doi.org\/10.1176\/appi.focus.20230009.","journal-title":"Focus (Madison)"},{"issue":"9","key":"1315_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/1099-1166(200009)15:9<779::AID-GPS191>3.0.CO;2-7","volume":"15","author":"J Snowdon","year":"2000","unstructured":"Snowdon J. The relevance of guidelines for treatment mania in old age. Int J Geriatr Psychiatry. 2000;15(9):779\u201383. https:\/\/doi.org\/10.1002\/1099-1166(200009)15:9%3c779::AID-GPS191%3e3.0.CO;2-7.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"1315_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00019442-200407000-00002","volume":"12","author":"RC Young","year":"2004","unstructured":"Young RC, Gyulai L, Mulsant BH, Flint A, Beyer JL, Shulman KI, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. 2004;12(4):342\u201357. https:\/\/doi.org\/10.1097\/00019442-200407000-00002.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"1315_CR43","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1002\/gps.4738","volume":"33","author":"P Marino","year":"2018","unstructured":"Marino P, Schulberg HC, Gildengers AG, Mulsant BH, Sajatovic M, Gyulai L, et al. Assessing bipolar disorder in the older adult: the GERI-BD toolbox. Int J Geriatr Psychiatry. 2018;33(1):e150\u20137. https:\/\/doi.org\/10.1002\/gps.4738.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"1315_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1176\/appi.focus.23021024","volume":"21","author":"N Ljubic","year":"2023","unstructured":"Ljubic N, Ueberberg B, Grunze H, Assion H-J. Treatment of bipolar disorders in older adults: a review. Focus J Life Long Learn Psychiatry. 2023;21(4):434\u201343. https:\/\/doi.org\/10.1176\/appi.focus.23021024.","journal-title":"Focus J Life Long Learn Psychiatry"},{"issue":"7396","key":"1315_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/bmj.326.7396.960","volume":"326","author":"KI Shulman","year":"2003","unstructured":"Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ Br Med J. 2003;326(7396):960\u20131. https:\/\/doi.org\/10.1136\/bmj.326.7396.960.","journal-title":"BMJ Br Med J."},{"issue":"5","key":"1315_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11920-025-01606-8","volume":"27","author":"AK Yocum","year":"2025","unstructured":"Yocum AK, Singh B. Global trends in the use of pharmacotherapy for the treatment of bipolar disorder. Curr Psychiatry Rep. 2025;27(5):239\u201347. https:\/\/doi.org\/10.1007\/s11920-025-01606-8.","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"1315_CR47","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/acps.13474","volume":"146","author":"OV Forlenza","year":"2022","unstructured":"Forlenza OV, Hajek T, Almeida OP, Beunders AJM, Blumberg HP, Briggs FBS, et al. Demographic and clinical characteristics of lithium-treated older adults with bipolar disorder. Acta Psychiatr Scand. 2022;146(5):442\u201355. https:\/\/doi.org\/10.1111\/acps.13474.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"1315_CR48","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/psyg.13197","volume":"24","author":"C-H Lin","year":"2024","unstructured":"Lin C-H, Hsu C-C, Chan H-Y, Chen J-J. Prescribing patterns for older-age bipolar disorder patients discharged from two public mental hospitals in Taiwan, 2006\u20132019. Psychogeriatrics. 2024;24(6):1324\u201334. https:\/\/doi.org\/10.1111\/psyg.13197.","journal-title":"Psychogeriatrics"},{"issue":"5","key":"1315_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/acps.70016","volume":"152","author":"OV Forlenza","year":"2025","unstructured":"Forlenza OV, Xu N, Chen P, Rej S, Gildengers AG, Hajek T, et al. Demographic and clinical characteristics of lithium-treated older adults with bipolar disorder: a replication study From the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) project. Acta Psychiatr Scand. 2025;152(5):393\u20136. https:\/\/doi.org\/10.1111\/acps.70016","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"1315_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11920-024-01576-3","volume":"27","author":"BE Donley","year":"2025","unstructured":"Donley BE, Garcia-Pittman EC. Outpatient management of bipolar disorder in older adults. Curr Psychiatry Rep. 2025;27(2):77\u201387. https:\/\/doi.org\/10.1007\/s11920-024-01576-3.","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"1315_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.64719\/pb.4431","volume":"52","author":"P Chen","year":"2022","unstructured":"Chen P, Eyler LT, Gildengers A, Beunders AJM, Blumberg HP, Briggs FBS, et al. Demographic and clinical characteristics of antipsychotic drug-treated older adults with bipolar disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE\u2013BD). Psychopharmacol Bull. 2022;52(2):8\u201333. https:\/\/doi.org\/10.64719\/pb.4431.","journal-title":"Psychopharmacol Bull"},{"key":"1315_CR52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jad.2025.04.006","volume":"381","author":"CM Steger","year":"2017","unstructured":"Steger CM, Birckhead B, Raghunath S, Straub J, Sthapit S, Albert MC, et al. Trends and determinants of prescription of lithium and antidepressants for bipolar disorder in a large health care system between 2017 and 2022. J Affect Disord. 2017;381:451\u20138. https:\/\/doi.org\/10.1016\/j.jad.2025.04.006.","journal-title":"J Affect Disord"},{"issue":"5","key":"1315_CR53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11920-025-01593-w","volume":"27","author":"M Orhan","year":"2025","unstructured":"Orhan M, Montejo L, Sajatovic M, Eyler L, Dols A. Global Aging & Geriatric Experiments in Bipolar Disorder (GAGE-BD): building a global consortium benefiting people with bipolar disorder in later life. Curr Psychiatry Rep. 2025;27(5):231\u20138. https:\/\/doi.org\/10.1007\/s11920-025-01593-w.","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"1315_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1176\/appi.ajp.2020.19091000","volume":"177","author":"TG Rhee","year":"2020","unstructured":"Rhee TG, Olfson M, Nierenberg AA, Wilkinson ST. 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. Am J Psychiatry. 2020;177(8):706\u201315. https:\/\/doi.org\/10.1176\/appi.ajp.2020.19091000.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1315_CR55","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.npp.1301492","volume":"33","author":"DV Jeste","year":"2008","unstructured":"Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider L, et al. ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008;33(5):957\u201370. https:\/\/doi.org\/10.1038\/sj.npp.1301492.","journal-title":"Neuropsychopharmacology"},{"key":"1315_CR56","unstructured":"Center for Drug Evaluation and Research. Postmarket drug safety information for patients and providers\u2014Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances [WebContent]. 2005. https:\/\/wayback.archive-it.org\/7993\/20170113112252\/http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm053171.htm. Accessed 19 June 2026."},{"issue":"12","key":"1315_CR57","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","volume":"8","author":"R Brauer","year":"2008","unstructured":"Brauer R, Alfageh B, Blais JE, Chan EW, Chui CSL, Hayes JF, et al. Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study. Lancet Psychiatry. 2008;8(12):1071\u201382. https:\/\/doi.org\/10.1016\/S2215-0366(21)00292-3.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"1315_CR58","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1176\/appi.focus.20230010","volume":"21","author":"A Dols","year":"2023","unstructured":"Dols A, Sekhon H, Rej S, Klaus F, Bodenstein K, Sajatovic M. Bipolar disorder among older adults: newer evidence to guide clinical practice. Focus (Am Psychiatr Publ). 2023;21(4):370\u20139. https:\/\/doi.org\/10.1176\/appi.focus.20230010.","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"1315_CR59","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2147\/NDT.S126708","volume":"13","author":"P De Fazio","year":"2017","unstructured":"De Fazio P, Gaetano R, Caroleo M, Pavia M, De Sarro G, Fagiolini A, et al. Lithium in late-life mania: a systematic review. Neuropsychiatr Dis Treat. 2017;13:755\u201366. https:\/\/doi.org\/10.2147\/NDT.S126708.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"1315_CR60","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1176\/appi.ajp.2017.15050657","volume":"174","author":"RC Young","year":"2017","unstructured":"Young RC, Mulsant BH, Sajatovic M, Gildengers AG, Gyulai L, Al Jurdi RK, et al. GERI-BD: a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. Am J Psychiatry. 2017;174(11):1086\u201393. https:\/\/doi.org\/10.1176\/appi.ajp.2017.15050657.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1315_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bdi.12714","volume":"21","author":"KI Shulman","year":"2019","unstructured":"Shulman KI, Almeida OP, Herrmann N, Schaffer A, Strejilevich SA, Paternoster C, et al. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: an ISBD task force report. Bipolar Disord. 2019;21(2):117\u201323. https:\/\/doi.org\/10.1111\/bdi.12714.","journal-title":"Bipolar Disord"},{"issue":"2","key":"1315_CR62","first-page":"153","volume":"34","author":"AWS Fung","year":"2023","unstructured":"Fung AWS, Shulman KI, Konforte D, Vandenberghe H, Stemp J, Yuan VR, et al. Age-stratified lithium therapeutic ranges for older adults with bipolar disorder\u2014from awareness to an action plan. EJIFCC. 2023;34(2):153\u201366.","journal-title":"EJIFCC."},{"key":"1315_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2026.121234","volume":"403","author":"HX Ng","year":"2026","unstructured":"Ng HX, Abe C, Alda M, Alonso-Lana S, Anmella G, Bauer J, et al. Brain aging in bipolar disorder using a neuroimaging and machine learning-derived metric: findings from the ENIGMA BD working group. J Affect Disord. 2026;403:121234. https:\/\/doi.org\/10.1016\/j.jad.2026.121234.","journal-title":"J Affect Disord"},{"key":"1315_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-026-02330-4","author":"LT Eyler","year":"2026","unstructured":"Eyler LT, Klaus F, Van Dyne A, Ng HX, Dols A, Sajatovic M. The spectrum of bipolar disorder in older adults. Neuropsychopharmacology. 2026. https:\/\/doi.org\/10.1038\/s41386-026-02330-4.","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"1315_CR65","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41386-020-0683-2","volume":"45","author":"KE Burdick","year":"2020","unstructured":"Burdick KE, Millett CE, Russo M, Alda M, Alliey-Rodriguez N, Anand A, et al. The association between lithium use and neurocognitive performance in patients with bipolar disorder. Neuropsychopharmacology. 2020;45(10):1743\u20139. https:\/\/doi.org\/10.1038\/s41386-020-0683-2.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1315_CR66","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/JCP.00000000000022072","volume":"46","author":"L Patarroyo-Rodriguez","year":"2026","unstructured":"Patarroyo-Rodriguez L, Leung J, Philbrick K, Choe J, Singh B. Tirzepatide-associated lithium toxicity necessitating hemodialysis in previously stable bipolar I disorder. J Clin Psychopharmacol. 2026;46(4):488\u201390. https:\/\/doi.org\/10.1097\/JCP.00000000000022072.","journal-title":"J Clin Psychopharmacol."},{"issue":"6","key":"1315_CR67","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/JCP.0000000000002090","volume":"45","author":"M Al-Soleiti","year":"2025","unstructured":"Al-Soleiti M, Leung JG, Mubaydeen T, Markota M, Abulseoud O, Singh B, et al. Lithium toxicity and altered clearance following initiation of semaglutide in patients with bipolar disorder: a case series and literature review. J Clin Psychopharmacol. 2025;45(6):613\u20138. https:\/\/doi.org\/10.1097\/JCP.0000000000002090.","journal-title":"J Clin Psychopharmacol."},{"issue":"2","key":"1315_CR68","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.23ac14813","volume":"84","author":"M Ercis","year":"2023","unstructured":"Ercis M, Ozerdem A, Singh B. When and how to use lithium augmentation for treating major depressive disorder. J Clin Psychiatry. 2023;84(2): 23ac14813. https:\/\/doi.org\/10.4088\/JCP.23ac14813.","journal-title":"J Clin Psychiatry."},{"key":"1315_CR69","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m12095","author":"S Rej","year":"2018","unstructured":"Rej S, Herrmann N, Gruneir A, Jandoc R, McArthur E, Dixon S, et al. Blood lithium monitoring practices in a population-based sample of older adults. J Clin Psychiatry. 2018. https:\/\/doi.org\/10.4088\/JCP.17m12095.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1315_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40266-014-0234-9","volume":"32","author":"S Rej","year":"2015","unstructured":"Rej S, Elie D, Mucsi I, Looper KJ, Segal M. Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders. Drugs Aging. 2015;32(1):31\u201342. https:\/\/doi.org\/10.1007\/s40266-014-0234-9.","journal-title":"Drugs Aging"},{"issue":"12","key":"1315_CR71","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40266-014-0221-1","volume":"31","author":"S Rej","year":"2014","unstructured":"Rej S, Beaulieu S, Segal M, Low NC, Mucsi I, Holcroft C, et al. Lithium dosing and serum concentrations across the age spectrum: from early adulthood to the tenth decade of life. Drugs Aging. 2014;31(12):911\u20136. https:\/\/doi.org\/10.1007\/s40266-014-0221-1.","journal-title":"Drugs Aging"},{"key":"1315_CR72","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2147\/NDT.S245166","volume":"16","author":"N Yalin","year":"2020","unstructured":"Yalin N, Young AH. Pharmacological treatment of bipolar depression: what are the current and emerging options? Neuropsychiatr Dis Treat. 2020;16:1459\u201372. https:\/\/doi.org\/10.2147\/NDT.S245166.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1315_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","volume":"28","author":"S Svalheim","year":"2015","unstructured":"Svalheim S, Sveberg L, Mochol M, Tauboll E. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12\u20137. https:\/\/doi.org\/10.1016\/j.seizure.2015.02.022.","journal-title":"Seizure."},{"issue":"4","key":"1315_CR74","doi-asserted-by":"publisher","first-page":"e000208","DOI":"10.1161\/JAHA.113.000208","volume":"2","author":"E Patorno","year":"2013","unstructured":"Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, et al. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc. 2013;2(4):e000208. https:\/\/doi.org\/10.1161\/JAHA.113.000208.","journal-title":"J Am Heart Assoc"},{"key":"1315_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18350-1","volume":"12","author":"W Moon","year":"2022","unstructured":"Moon W, Ji E, Shin J, Kwon JS, Kim KW. Effect of valproate and lithium on dementia onset risk in bipolar disorder patients. Sci Rep. 2022;12:14142. https:\/\/doi.org\/10.1038\/s41598-022-18350-1.","journal-title":"Sci Rep"},{"issue":"4","key":"1315_CR76","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1176\/appi.ajgp.13.4.305","volume":"13","author":"M Sajatovic","year":"2005","unstructured":"Sajatovic M, Gyulai L, Calabrese JR, Thompson TR, Wilson BG, White R, et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry. 2005;13(4):305\u201311. https:\/\/doi.org\/10.1176\/appi.ajgp.13.4.305.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"1315_CR77","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3122\/jabfm.2007.05.070062","volume":"20","author":"J Wadzinski","year":"2007","unstructured":"Wadzinski J, Franks R, Roane D, Bayard M. Valproate-associated hyperammonemic encephalopathy. J Am Board Fam Med. 2007;20(5):499\u2013502. https:\/\/doi.org\/10.3122\/jabfm.2007.05.070062.","journal-title":"J Am Board Fam Med"},{"key":"1315_CR78","unstructured":"AbbVie Inc. Depakote (divalproex sodium) [prescribing information] North Chicago, IL2026 [updated 2026 March. DailyMed drug label. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=08a65cf4-7749-4ceb-6895-8f4805e2b01f. Accessed 19 June 2026."},{"issue":"6","key":"1315_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57060587","volume":"57","author":"I Arnold","year":"2021","unstructured":"Arnold I, Dehning J, Grunze A, Hausmann A. Old age bipolar disorder\u2014epidemiology, aetiology and treatment. Medicina (B Aires). 2021;57(6):587. https:\/\/doi.org\/10.3390\/medicina57060587.","journal-title":"Medicina (B Aires)"},{"issue":"3","key":"1315_CR80","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1399-5618.2011.00923.x","volume":"13","author":"M Sajatovic","year":"2011","unstructured":"Sajatovic M, Gildengers A, Al Jurdi RK, Gyulai L, Cassidy KA, Greenberg RL, et al. Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report. Bipolar Disord. 2011;13(3):294\u2013302. https:\/\/doi.org\/10.1111\/j.1399-5618.2011.00923.x.","journal-title":"Bipolar Disord"},{"key":"1315_CR81","doi-asserted-by":"publisher","first-page":"204512532110458","DOI":"10.1177\/20451253211045870","volume":"11","author":"FMC Besag","year":"2021","unstructured":"Besag FMC, Vasey MJ, Sharma AN, Lam ICH. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol. 2021;11:20451253211045870. https:\/\/doi.org\/10.1177\/20451253211045870.","journal-title":"Ther Adv Psychopharmacol."},{"issue":"6","key":"1315_CR82","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1399-5618.2008.00614.x","volume":"10","author":"M Sajatovic","year":"2008","unstructured":"Sajatovic M, Calabrese JR, Mullen J. Quetiapine for the treatment of bipolar mania in older adults. Bipolar Disord. 2008;10(6):662\u201371. https:\/\/doi.org\/10.1111\/j.1399-5618.2008.00614.x.","journal-title":"Bipolar Disord"},{"key":"1315_CR83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.archger.2016.01.012","volume":"64","author":"Y Barak","year":"2016","unstructured":"Barak Y, Finkelstein I, Pridan S. The geriatric mania asenapine study (GeMS). Arch Gerontol Geriatr. 2016;64:111\u20134. https:\/\/doi.org\/10.1016\/j.archger.2016.01.012.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"1315_CR84","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jad.2012.05.027","volume":"145","author":"Y Baruch","year":"2013","unstructured":"Baruch Y, Tadger S, Plopski I, Barak Y. Asenapine for elderly bipolar manic patients. J Affect Disord. 2013;145(1):130\u20132. https:\/\/doi.org\/10.1016\/j.jad.2012.05.027.","journal-title":"J Affect Disord"},{"key":"1315_CR85","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2147\/CIA.S63942","volume":"9","author":"P Gareri","year":"2014","unstructured":"Gareri P, Segura-Garc\u00eda C, Manfredi VGL, Bruni A, Ciambrone P, Cerminara G, et al. Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging. 2014;9:1363\u201373. https:\/\/doi.org\/10.2147\/CIA.S63942.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"1315_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4088\/jcp.v69n0106","volume":"69","author":"M Sajatovic","year":"2008","unstructured":"Sajatovic M, Coconcea N, Ignacio RV, Blow FC, Hays RW, Cassidy KA, et al. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. J Clin Psychiatry. 2008;69(1):41\u20136. https:\/\/doi.org\/10.4088\/jcp.v69n0106.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1315_CR87","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jagp.2017.08.013","volume":"26","author":"BP Forester","year":"2018","unstructured":"Forester BP, Sajatovic M, Tsai J, Pikalov A, Cucchiaro J, Loebel A. Safety and effectiveness of long-term treatment with lurasidone in older adults with bipolar depression: post-hoc analysis of a 6-month, open-label study. Am J Geriatr Psychiatry. 2018;26(2):150\u20139. https:\/\/doi.org\/10.1016\/j.jagp.2017.08.013.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"1315_CR88","doi-asserted-by":"publisher","first-page":"e1324","DOI":"10.4088\/JCP.15m10261","volume":"77","author":"M Sajatovic","year":"2016","unstructured":"Sajatovic M, Forester BP, Tsai J, Kroger H, Pikalov A, Cucchiaro J, et al. Efficacy of lurasidone in adults aged 55 years and older with bipolar depression: post hoc analysis of 2 double-blind, placebo-controlled studies. J Clin Psychiatry. 2016;77(10):e1324\u201331. https:\/\/doi.org\/10.4088\/JCP.15m10261.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"1315_CR89","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jagp.2024.12.006","volume":"33","author":"N Garel","year":"2025","unstructured":"Garel N, Dols A, Yu J, Cresce CD, Rej S, Sajatovic M. Effect of cariprazine on outcomes in older-aged and younger-aged patients with bipolar I disorder: a post-hoc analysis. Am J Geriatr Psychiatry. 2025;33(4):372\u201386. https:\/\/doi.org\/10.1016\/j.jagp.2024.12.006.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"1315_CR90","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/104012371102300107","volume":"23","author":"M Weiner","year":"2011","unstructured":"Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011;23(1):40\u20137. https:\/\/doi.org\/10.1177\/104012371102300107.","journal-title":"Ann Clin Psychiatry"},{"issue":"6","key":"1315_CR91","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/YIC.0000000000000421","volume":"37","author":"C Elefante","year":"2022","unstructured":"Elefante C, Brancati GE, Petrucci A, Gemmellaro T, Toni C, Lattanzi L, et al. Risk of conversion to bipolar disorder in patients with late-onset major depression. Int Clin Psychopharmacol. 2022;37(6):234. https:\/\/doi.org\/10.1097\/YIC.0000000000000421.","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"1315_CR92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S2215-0366(25)00026-4","volume":"12","author":"B Singh","year":"2025","unstructured":"Singh B. Lithium for depression-related hospitalisation in bipolar disorder. Lancet Psychiatry. 2025;12(3):165\u20136. https:\/\/doi.org\/10.1016\/S2215-0366(25)00026-4.","journal-title":"Lancet Psychiatry."},{"issue":"5","key":"1315_CR93","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1192\/bjp.2019.76","volume":"215","author":"OV Forlenza","year":"2019","unstructured":"Forlenza OV, Radanovic M, Talib LL, Gattaz WF. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. Br J Psychiatry. 2019;215(5):668\u201374. https:\/\/doi.org\/10.1192\/bjp.2019.76.","journal-title":"Br J Psychiatry"},{"issue":"7","key":"1315_CR94","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/bdi.13052","volume":"23","author":"M Pahwa","year":"2021","unstructured":"Pahwa M, Joseph B, Nunez NA, Jenkins GD, Colby CL, Kashani KB, et al. Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: a historical cohort study. Bipolar Disord. 2021;23(7):715\u201323. https:\/\/doi.org\/10.1111\/bdi.13052.","journal-title":"Bipolar Disord."},{"issue":"1","key":"1315_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bdi.13501","volume":"27","author":"AK Parsaik","year":"2024","unstructured":"Parsaik AK, Chaudhary A, Sharma S, Delgoffe BE, Gabor R, Singh B. Effects of long-term lithium therapy on kidney functioning in mood disorders: a population-based historical cohort study. Bipolar Disord. 2024;27(1):28\u201335. https:\/\/doi.org\/10.1111\/bdi.13501.","journal-title":"Bipolar Disord."},{"issue":"4","key":"1315_CR96","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/104012371702900410","volume":"29","author":"J Szpunar","year":"2017","unstructured":"Szpunar J, Maeshima H, Grossberg GT. Renal concerns relative to the use of lithium in geriatric bipolar disorder patients. Ann Clin Psychiatry. 2017;29(4):283\u201390. https:\/\/doi.org\/10.1177\/104012371702900410.","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"1315_CR97","doi-asserted-by":"publisher","first-page":"403","DOI":"10.9758\/cpn.2022.20.3.403","volume":"20","author":"C Crapanzano","year":"2022","unstructured":"Crapanzano C, Casolaro I, Amendola C, Damiani S. Lithium and valproate in bipolar disorder: from international evidence-based guidelines to clinical predictors. Clin Psychopharmacol Neurosci. 2022;20(3):403\u201314. https:\/\/doi.org\/10.9758\/cpn.2022.20.3.403.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"3","key":"1315_CR98","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1755-5949.2011.00255.x","volume":"18","author":"JM Azorin","year":"2012","unstructured":"Azorin JM, Kaladjian A, Adida M, Fakra E. Late-onset bipolar illness: the geriatric bipolar type VI. CNS Neurosci Ther. 2012;18(3):208\u201313. https:\/\/doi.org\/10.1111\/j.1755-5949.2011.00255.x.","journal-title":"CNS Neurosci Ther"},{"issue":"15","key":"1315_CR99","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","volume":"46","author":"RM Nanau","year":"2013","unstructured":"Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem. 2013;46(15):1323\u201338. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.06.012.","journal-title":"Clin Biochem"},{"issue":"6","key":"1315_CR100","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1017\/S1041610215002380","volume":"28","author":"S Rej","year":"2016","unstructured":"Rej S, Schuurmans J, Elie D, Stek ML, Shulman K, Dols A. Attitudes towards pharmacotherapy in late-life bipolar disorder. Int Psychogeriatr. 2016;28(6):945\u201350. https:\/\/doi.org\/10.1017\/S1041610215002380.","journal-title":"Int Psychogeriatr"},{"issue":"12","key":"1315_CR101","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/gps.4635","volume":"32","author":"S Rej","year":"2017","unstructured":"Rej S, Herrmann N, Shulman K, Fischer HD, Fung K, Gruneir A. Current psychotropic medication prescribing patterns in late-life bipolar disorder. Int J Geriatr Psychiatry. 2017;32(12):1459\u201365. https:\/\/doi.org\/10.1002\/gps.4635.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"10","key":"1315_CR102","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1517\/14656566.3.10.1513","volume":"3","author":"CL Bowden","year":"2002","unstructured":"Bowden CL. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother. 2002;3(10):1513\u20139. https:\/\/doi.org\/10.1517\/14656566.3.10.1513.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"1315_CR103","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/070674370204700808","volume":"47","author":"M Robillard","year":"2002","unstructured":"Robillard M, Conn DK. Lamotrigine use in geriatric patients with bipolar depression. Can J Psychiatry. 2002;47(8):767\u201370. https:\/\/doi.org\/10.1177\/070674370204700808.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"1315_CR104","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/JCP.0000000000001475","volume":"41","author":"R Kumar","year":"2021","unstructured":"Kumar R, Nu\u00f1ez NA, Prokop LJ, Veldic M, Betcher H, Singh B. Association of optimal lamotrigine serum levels and therapeutic efficacy in mood disorders: a systematic review. J Clin Psychopharmacol. 2021;41(6):681\u20136. https:\/\/doi.org\/10.1097\/JCP.0000000000001475.","journal-title":"J Clin Psychopharmacol."},{"issue":"7","key":"1315_CR105","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/gps.4213","volume":"30","author":"M Sajatovic","year":"2015","unstructured":"Sajatovic M, Dines P, Fuentes-Casiano E, Athey M, Cassidy KA, Sams J, et al. Asenapine in the treatment of older adults with bipolar disorder. Int J Geriatr Psychiatry. 2015;30(7):710\u20139. https:\/\/doi.org\/10.1002\/gps.4213.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1315_CR106","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jad.2019.07.054","volume":"257","author":"M Tournier","year":"2019","unstructured":"Tournier M, Neumann A, Pambrun E, Weill A, Chaffiol JP, Alla F, et al. Conventional mood stabilizers and\/or second-generation antipsychotic drugs in bipolar disorders: a population-based comparison of risk of treatment failure. J Affect Disord. 2019;257:412\u201320. https:\/\/doi.org\/10.1016\/j.jad.2019.07.054.","journal-title":"J Affect Disord"},{"issue":"11","key":"1315_CR107","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","volume":"170","author":"I Pacchiarotti","year":"2013","unstructured":"Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170(11):1249\u201362. https:\/\/doi.org\/10.1176\/appi.ajp.2013.13020185.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"1315_CR108","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/brainsci13121672","volume":"13","author":"NA Nunez","year":"2023","unstructured":"Nunez NA, Joseph B, Kumar R, Douka I, Miola A, Prokop LJ, et al. An update on the efficacy of single and serial intravenous ketamine infusions and esketamine for bipolar depression: a systematic review and meta-analysis. Brain Sci. 2023;13(12):1672. https:\/\/doi.org\/10.3390\/brainsci13121672.","journal-title":"Brain Sci."},{"issue":"3","key":"1315_CR109","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/JCP.0000000000000326","volume":"35","author":"BP Forester","year":"2015","unstructured":"Forester BP, Harper DG, Georgakas J, Ravichandran C, Madurai N, Cohen BM. Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression. J Clin Psychopharmacol. 2015;35(3):338\u201340. https:\/\/doi.org\/10.1097\/JCP.0000000000000326.","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"1315_CR110","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2146\/ajhp070279","volume":"65","author":"WR Zemrak","year":"2008","unstructured":"Zemrak WR, Kenna GA. Association of antipsychotic and antidepressant drugs with Q-T interval prolongation. Am J Health Syst Pharm. 2008;65(11):1029\u201338. https:\/\/doi.org\/10.2146\/ajhp070279.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"1315_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-022-00271-7","volume":"10","author":"T Maruki","year":"2022","unstructured":"Maruki T, Utsumi T, Takeshima M, Fujiwara Y, Matsui M, Aoki Y, et al. Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials. Int J Bipolar Disord. 2022;10(1):24. https:\/\/doi.org\/10.1186\/s40345-022-00271-7.","journal-title":"Int J Bipolar Disord"},{"key":"1315_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01659","volume":"10","author":"G Loggia","year":"2019","unstructured":"Loggia G, Attoh-Mensah E, Pothier K, Morello R, Lescure P, Bocca ML, et al. Psychotropic polypharmacy in adults 55 years or older: a risk for impaired global cognition, executive function, and mobility. Front Pharmacol. 2019;10:1659. https:\/\/doi.org\/10.3389\/fphar.2019.01659.","journal-title":"Front Pharmacol"},{"issue":"8","key":"1315_CR113","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1176\/appi.ps.201500359","volume":"67","author":"S Gupta","year":"2016","unstructured":"Gupta S, Cahill JD. A prescription for \u201cdeprescribing\u201d in psychiatry. Psychiatr Serv (Wash, DC). 2016;67(8):904\u20137. https:\/\/doi.org\/10.1176\/appi.ps.201500359.","journal-title":"Psychiatr Serv (Wash, DC)"},{"issue":"3","key":"1315_CR114","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-018-0881-3","volume":"20","author":"J de Leon","year":"2018","unstructured":"de Leon J, Spina E. Possible pharmacodynamic and pharmacokinetic drug-drug interactions that are likely to be clinically relevant and\/or frequent in bipolar disorder. Curr Psychiatry Rep. 2018;20(3):17. https:\/\/doi.org\/10.1007\/s11920-018-0881-3.","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"1315_CR115","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/s41380-024-02445-4","volume":"29","author":"CH Vinkers","year":"2024","unstructured":"Vinkers CH, Kupka RW, Penninx BW, Ruhe HG, van Gaalen JM, van Haaren PCF, et al. Discontinuation of psychotropic medication: a synthesis of evidence across medication classes. Mol Psychiatry. 2024;29(8):2575\u201386. https:\/\/doi.org\/10.1038\/s41380-024-02445-4.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1315_CR116","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa2300184","volume":"389","author":"LN Yatham","year":"2023","unstructured":"Yatham LN, Arumugham SS, Kesavan M, Ramachandran K, Murthy NS, Saraf G, et al. Duration of adjunctive antidepressant maintenance in bipolar I depression. N Engl J Med. 2023;389(5):430\u201340. https:\/\/doi.org\/10.1056\/NEJMoa2300184.","journal-title":"N Engl J Med"},{"issue":"4","key":"1315_CR117","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4088\/JCP.08m04909gre","volume":"71","author":"SN Ghaemi","year":"2010","unstructured":"Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, et al. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010;71(4):372\u201380. https:\/\/doi.org\/10.4088\/JCP.08m04909gre.","journal-title":"J Clin Psychiatry"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01315-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:26:58Z","timestamp":1785515218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01315-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01315-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Balwinder Singh has received research grant support from Mayo Clinic, the National Network of Depression Centers, Breakthrough Discoveries for Thriving with Bipolar Disorder and NIH. He is a KL2 Mentored Career Development Program scholar, supported by CTSA Grant Number KL2 TR002379 from the NCATS. Dr. Singh has received honoraria (to Mayo Clinic) from Elsevier for editing a Clinical Overview on Treatment-Resistant Depression. Other authors report no potential conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final submitted manuscript and agree to be accountable for the work.","order":7,"name":"Ethics","label":"Author\u2019s contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}